EDAIC - European Diploma in Anesthesiology and Intensive Care Pharmacokinetics and Pharmacodynamics Questions and Answers — Questions and Answers
Question 1: A 68-year-old patient with Child-Pugh Class C liver cirrhosis is anesthetized for a TIPS procedure. Fentanyl, a highly protein-bound opioid with a high hepatic extraction ratio, is administered. Which pharmacokinetic changes are most significant in this patient compared to a healthy individual?
- Decreased volume of distribution and increased hepatic clearance.
- Increased plasma protein binding and a higher first-pass metabolism.
- Decreased drug potency at the mu-opioid receptor.
- Increased free drug fraction and decreased hepatic clearance. (Correct answer)
Correct answer: Increased free drug fraction and decreased hepatic clearance.
In severe liver disease, synthesis of plasma proteins like albumin is reduced, leading to less protein binding and a higher fraction of unbound, pharmacologically active drug. Additionally, both liver blood flow and enzymatic function are impaired, which significantly decreases the clearance of drugs with a high hepatic extraction ratio, like fentanyl. This combination leads to a more pronounced and prolonged effect.
Question 2: Which of the following statements accurately describes the effect of a non-competitive antagonist on an agonist's dose-response curve?
- A parallel rightward shift, with no change in maximal effect.
- A depression of the maximal effect (Emax), which cannot be overcome by increasing the agonist concentration. (Correct answer)
- An increase in the agonist's potency (lower EC50).
- A parallel leftward shift, with an increase in maximal effect.
Correct answer: A depression of the maximal effect (Emax), which cannot be overcome by increasing the agonist concentration.
A non-competitive antagonist binds to the receptor at an allosteric site or binds irreversibly to the active site, effectively removing functional receptors from the system. This reduces the maximum possible response (Emax) that can be achieved, regardless of how much agonist is administered. In contrast, a competitive antagonist causes a rightward shift in the curve (decreased potency) but the same Emax can be reached with a higher agonist concentration.
Question 3: A 55-year-old patient with combined severe renal and hepatic failure requires a continuous opioid infusion for sedation in the ICU. Which of the following opioids would provide the most predictable and rapid offset of effect upon discontinuation of the infusion?
- Fentanyl
- Morphine
- Remifentanil (Correct answer)
- Hydromorphone
Correct answer: Remifentanil
Remifentanil is metabolized by non-specific esterases in the blood and peripheral tissues, a process that is independent of hepatic or renal function. This unique pathway results in a very short and consistent context-sensitive half-time (approximately 3-4 minutes) that does not increase significantly with the duration of the infusion. Fentanyl, morphine, and hydromorphone all rely on hepatic metabolism and/or renal clearance, leading to unpredictable accumulation and prolonged effects in patients with organ failure.
Question 4: A 70-year-old patient with anuria due to end-stage renal disease requires neuromuscular blockade for an emergency laparotomy. Which of the following neuromuscular blocking agents would have the most significantly prolonged duration of action?
- Atracurium
- Pancuronium (Correct answer)
- Succinylcholine
- Cisatracurium
Correct answer: Pancuronium
Pancuronium is a long-acting neuromuscular blocker that is primarily cleared by the kidneys (approximately 80% renal excretion). In a patient with anuria, its clearance is drastically reduced, leading to a markedly prolonged duration of action and a risk of postoperative residual paralysis. In contrast, atracurium and cisatracurium undergo organ-independent Hofmann elimination, and succinylcholine is metabolized by plasma pseudocholinesterase, making their durations of action largely unaffected by renal failure.
Question 5: The 'context-sensitive half-time' is a critical pharmacokinetic concept for predicting recovery after an intravenous drug infusion. It is defined as the time required for:
- 50% of the total drug dose to be eliminated from the body.
- the plasma drug concentration to decrease by 50% after stopping an infusion of a specific duration. (Correct answer)
- the drug concentration at the effect site to reach 50% of its peak.
- the drug to be completely metabolized by the liver, independent of infusion time.
Correct answer: the plasma drug concentration to decrease by 50% after stopping an infusion of a specific duration.
The context-sensitive half-time is the time taken for the plasma concentration of a drug to decrease by 50% after stopping an infusion of a certain duration (the 'context'). It is a more clinically useful measure than elimination half-life for infused drugs because it accounts for the redistribution of the drug from peripheral tissues back into the central compartment, which can significantly prolong the drug's effect. For many lipophilic drugs like fentanyl, the context-sensitive half-time increases with the duration of the infusion.
Question 6: In pharmacodynamics, Drug X has an EC50 of 2 mg, while Drug Y has an EC50 of 10 mg. Both drugs are full agonists at the same receptor and can produce the same maximal analgesic effect. Which of the following statements correctly compares the two drugs?
- Drug X and Drug Y have equal potency.
- Drug Y is more efficacious than Drug X.
- Drug X is more potent, but they have equal efficacy. (Correct answer)
- Drug X is more efficacious and more potent than Drug Y.
Correct answer: Drug X is more potent, but they have equal efficacy.
Potency is a measure of the dose required to produce a specific effect. It is quantified by the EC50 (the concentration or dose required to produce 50% of the maximal effect). A lower EC50 means a higher potency. Therefore, Drug X is more potent than Drug Y. Efficacy refers to the maximal effect (Emax) a drug can produce. Since both drugs can produce the same maximal analgesic effect, they have equal efficacy.
EDAIC - European Diploma in Anesthesiology and Intensive Care Pharmacokinetics and Pharmacodynamics Questions and Answers
A 68-year-old patient with Child-Pugh Class C liver cirrhosis is anesthetized for a TIPS procedure.
Fentanyl, a highly protein-bound opioid with a high hepatic extraction ratio, is administered.
Which pharmacokinetic changes are most significant in this patient compared to a healthy individual?